Macrophage-targeting nano-formulated bicalutamide alleviates colitis by inducing MAP3K1-mediated degradation of NLRP3

Suqin Zhong(Guangdong Academy of Medical Sciences), Xueqing Yao(Ganzhou People's Hospital), Yinyin Yang(Guangdong Academy of Medical Sciences), Xiaowan Huang(Dongbei University of Finance and Economics), Youcui Xu(Binzhou University), Yi Wu(National Science Centre), Zhiyuan Liu(Tongji University), Shanshan Li(University of Science and Technology of China), Yangyang Zhu(Guangdong Academy of Medical Sciences), Xinfeng Wang(South China University of Technology), Suzhen Zhong(Guangdong General Hospital), Yu Wu(National Science Centre), Zhengang Zhou(Guangdong Academy of Medical Sciences), Longping Wen(Guangdong Academy of Medical Sciences)
Journal of Controlled Release
February 10, 2025
Cited by 3


Related Papers